Lonza Group AG (LZAGY)
Manufactures drugs and biological treatments for pharmaceutical and biotech companies.
$68.59+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-1.5%
The outlook
Lonza Group trades at $68.59, positioning itself above both its 50- and 200-day moving averages with solid technical footing. Analysts lean toward a "Buy" rating, and the average price target sits roughly 18% above the current level. The stock sits in the upper two-thirds of its 52-week range, though the trailing P/E of 36.3 reflects a premium valuation.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Price targetAvg target +18% vs current price
Analyst price target
~12-month · 3 analysts$81.24average target+18.4% vs now
Now $68.59
Low $78.21High $86.74
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$48.80B
52-wk high
$73.85
52-wk low
$58.53
50-day avg
$65.42
200-day avg
$66.23
Trailing P/E
36.3